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eter stenosis. This clinical benefit was achieved without adversely affecting
other important aspects of the intewention. Procedural variables (expressed
per lesion; ICUS group vs standard group) which were not different between
the two groups included: rate of stent implantation (49% vs 49%, p = ns),
procedure time (63 *37 vs 6 + 36 rein, p = ns), contrast use (207+ 104 vs
197 + 97, p = ns), and maximal inflation pressure (12.4 k 3.6 vs 12,2 + 6.1
atm, p = ns). Device consumption (expresaed per lesion) favored the ICUS-
guided group: # balloons (1.22 * 0.94 vs 1.39 * 1.03, p = 0.10), #stents
(0.84 + 0.98 vs 0.62 & 0.94, p = ns), guide catheters (1.01 & 0.81 vs 1.10 +
0.77, p = ne) and guide wires (1.0* 0.76 vs 1.08 + 0.77, p = ns).
Weconclude that the benefitSof ICUS-guided interventionmaybe achieved
at no increase in procedure time or adverse effect on device utilization. The
long term coet effectiveness of this strategy will be assessed after 6 month
follow up now in progress.
D99448 Longitudinal Radiatribution of Plaqua ia anImportant Mechanism for Lumen Expansion in
Stenting
Y. Honda, C.A. Yock, J.B. Hermiller, P.J. Fitzgerald, P.G.Yock, for the
MULTI-LINK’MInvestigator. Stanford Univereiv, %enford, CA, USA, .9.
Vincent Hospital, Indianapolis, IN, USA
The mechanism for increasing lumen dimensions in coronay stents is poorly
understood. The ACS MULTI-LINK’” Stent has the unique property that the
media-adventitia interface can be clearly visualized through the stent with
intracoronaty ultrasound (lVUS). Analysis of the IVUScross-sectional images
of 47 patients treated with this stent showed a 10.2% (p < 0.01) decrease
in plaque area in the stented lesion between deployment (8 atm) and final
postdilatation (216 atm). There was a corresponding trend for increased
plaque area in the reference segments (7.6%, p = 0.2). To further determine
the mechanism of Iuminal improvement, we performed serial volumetric
IVUS analysis in eight coronay lesions. Motorized transducer pullback at 0.5
mtisec enabled measurements of vessel, plaque and stent or lumen areas
at 1 mm axial intervals. Calculated vessel, lumen, and plaque volumes (PV)
using Simpson’s rule at the stent and the reference sites were compared
before and after balloon inflations. Resu/fs: [1] Plaque volume in the stented
region significantly decreased after additional balloon inflation (p c 0.05)
while no significant increase in vessel volume was observed. [2] Plaque
volume at the reference sites significantly increased after inflation (p < 0.01);
however, the total plaque volume of the stent plus reference sites remained
unchanged.
w 20 1 t
10-
a
6-10-
1 I
-30 ~*p4,05
Proximal Stent Distaf -
Reference Reference
Cone/usiorr: Longitudinal redistribution of plaque out of stents, rather
than vessel expansion or plaque compression, appears to be a primary
mechanism of lumen gain after balloon inflation inside the stent.
D99449 Ultrasound (lCUS)-Guided Intervention Reaults inFewer Acute Major Adverae Cardiac Events
(MACE): Findings From the Strategy of
ICUS-Guided PTCA and Stenting (SIPS) Trial
A.W. Frey, C. Muller, H. Roskamm, J.McB. Hodgson. fferz Zentr’um,Bad
Krozingen, Germany
The SIPS trial randomized all consecutive patients except those with chronic
total occlusions to an interventional strategy of either primary treatment using
a combined ICUS/balloon catheter (Oracle Focus, Endosonics) (ICUS group)
or standard angiographically guided therapy (STD group) (n = 269 patients,
355 lesions). Procedural success was obtained in 96.7% of the ICUS and
Patisnta Infarct TLR MACE
Icus STD Icus STD Icus STD
All 1 (0.8) 3 (2.0) 2 (1,6) 8 (5.4) 3 (2.5) 11 (7,4)*
PTCA o 2 (1.4) 1 (0.8) 7 (4.7)* 1 (0.8) 9 (6.1)”
Stent 1 (0.8) 1 (0.7) 1 (0.8) 1 (0.7) 2 (1.6) 2 (1.4)
lChi-equare p < 0.05
92.6%of the STDgroup. Acute phase in-hospital myocardial infarction, target
lesion revascularization (TLR), and total MACE were compared. Stents were
placed in 49% of each group (p = ns). There were no deaths. Data in the
table displayed as # patients (Y.).
We conclude that acute MACE are reduced by a strategy of ICUS-guided
intervention. In this group of consecutive patients, such a strategy reduced
serious events by 66%. The beneficial effeti was confined to those patients
having only PTCA. The late clinical impact of this strategy will be assessed
after 6 month follow up angiography.
1994-501 Role of AdjunctiveBalloon Angioplasty Following
Coronary Atherectomy: A Serial Intravascular
Ultrasound Analysis from tha ABACAS Trial
H. Hosokawa, O. Kate, H. Tamai, T. Yamaguchi, T. Aizawa, T. Suzuki, for
the ABACAS Investigators. National ToyohashiHigashi Hospital, Toyohashi,
Japan
Adjunctive BalloonAngioplasty Following Coronary Atherectomy Study(ABA-
CAS) isa randomized multicenter registry to assess the impact of aggressive
debuiking using intravascular ultrasound (IVUS) guidance and adjunetive
PTCA on acute and long-term outcomes. A total of 214 patients (pts) were
prospectively randomized to DCA alone or to DCA with adjunct PTCA. In
66 pts out of 214 pts, prospective serial IVUS was performed at pre and
post-procedure, and at 6 months or earner if symptoms occurred.
Resu/ts: IVUS parameters at lesion site areas follows:
DCA alone (n = 43) DCA + PTCA (n= 41) P
Vessel CSA pre 14,7 * 18,6 15.9 + 26.2 ns
post 15.7 + 16.7 17.9 + 25.4 0.02
6M FU 15.6 + 24,0 16.5 + 30.3 ns
LumenCSA pre 3.3 & 2.7 3.5 * 3.0 na
peat 8,6 k 6.4 10.1 * 9.7 0.01
6M FU 6.1 + 10.1 6.1 + lo.a ns
P + M CSA pre 11.5 + 17.2 12.5 + 20,5 ns
poet 7.1 + 9.6 7.8 + 11,6 ns
6M FU 9.5 * 9.5 10.4 + 21.6 ns
CSA = cross-sectionalaree (mm2), P + M = plaque+ media
Before randomization (post-DCA), sufficient dubulking was achieved up
to a % plaque CSA of 46Y0in both group. Angiographic restenosis (% DS >
50%) occurred in 167. with no significant difference between DCA alone and
DCA + PTCA (16% VS 17%, p = NS).
Cone/usions.’After aggressive DCA, adjunctive PTCAcanachieve a larger
lumen, mainly by causing an enlargement of vessel area. However, serial
IVUS study showed no beneficial effect of adjunctive PTCAfollowing DCA at
follow-up.
1994-251OutcOmeAfterRecana,i~tionof Chronic Coronary
Occlusions in Relation to Quantitative
Intravascular Ultrasound Findings
GS. Werner, J. Diedrich, A.B. Buchwald, H. Kreuzer. Dept. of Cardiology
University of Goeffingen, Germany
Chronic coronary occlusions (TCO) carry a high recurrence rate after coro-
nary angioplasty (PTCA). To determine potanfial factors of Iata outcome,
intravascular ultrasound (NJ)measurements after recanalization were mm-
pared in vessels with and without raocclusion or raetenosis. 62 consecutive
pts with a TCO (duration more than 4 weeks) underwent IU during a suc-
cessful recenalization. On-line IU measurement of the proximal and distal
reference segment were done to adjust the balloon size. The Iuminal area
(LA), the area stenosis (LS), and the lumen deficit (LD) relative to the bal-
loon size, were calculated. In 30 cases of dissections (n = 13), or a LS >
50% coronary stents were implanted. 65Y0of all pts completed angiographic
follow-up after6 months. The balloon size forthefinal dilatation was adjusted
according to the IU measurement of the reference segments. In stented ves-
sels LS was –8 * 6% vs. 26 + 12% in nonstented vessels (p < 0.001),
and LD 23 + 97. vs. 37 + 14% (p < 0.01). 6 reocclusions and 9 reatenosis
were obsewed in nonstented vessels, one subacute stent thrombosis, no late
reocclusion and 4 restenosis were observed in stented vessels. Considering
only those pts, who had completed control angiography, the recurrence rate
without stent was 62’%.,and 22% with stents. When comparing outcome and
quantitative IU measurements durfng recanalization in nonstented vessels,
LA was lower in vessels with recurrence (4.0 + 1.3 vs. 5.3 & 1.6 mm2, p <
0.05), and LD was higher (39 + 137. vs 29 & 12%; p c 0.05). Likewise in
stented lesions, LA was significantly smaller in restenotic lesions (5.7 l 1.4
mmZVs7,9 & 1.9 mmz;p<0.05), whereas LD was similar.
The high recurrence rate in TCO appeared to be related to the absolute
Iuminalarea achieved by PTCA.Stent implantation with a Iargeracute Iuminal
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areaand low recoil after PTCA reduced the restenosis rate. Inorder to reduce
the recurrence rate, lesions with high recoil andalow LAshouldreceive stente
with optimum expansion.
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D99558 Apoptosisin Cardiomyopathy
T. Yamamura, H. Nakemura, T. Yamamoto, T. Fujii, N. Kobayasi,
M. Matsuzaki. The Second Depafiment of internal Medicine, Yamaguchi
University SchooiofMedicine, Ube, Nagasaki University Nagasaki, Japan
Fae/Fas Iigand interactions serve as a signaling pathway for apoptosis. We
elucidated the role of apoptosis on the progression in myocerdial damage
in dilated (DCM) and hypertrophic cardiomyopathy (HCM). Methoda: Total
34 patients (DCM:15, HCM:16 and normal control (N):3) were entered and
cardiac cethetelization and endmyocerdial biopsy (EMB)were performed. All
samples were serially sectioned and analyzed pathologically. Expression of
Fas antigen was investigated using immunostaining with polyclonal anti-Faa
antibody and the intensity of Fas expression was graded semiquantitatively
(Opoint: none - 3: > 30%). For the detection of apoptic cells, in situ TdT
staining was performed. Each 6 pieces of magnified photographs were used
for counting the number of apoptic cells. For clinical application, the relation
between hemodynamic parameters of cardiac function and immunohisto-
Iogical results were investigated atavistically.Ffeau/fs:The intensity of Faa
antigen on myocardium in DCM (216 k 0.19) was significantly higher than
that of HCM (1.33 + 0.23, p < 0.05), while the intensity of Fas antigen in N
(0.33 + 0.33) was significantly less than both groups. The mean incidence
rate of apoptic cells in DCM was also higher (15.56 + 3.24%) than that of
HCM (10.40* 1.74%), and theapoptic cells corresponded with Faa positive
cells. No apoptic cell was found in N. The incidence rate of apoptic cells was
higher in tha patients with lower EF (S 30%, 9.29 + 1.62%) than the patients
with highar EF (=-30Y0,24.17+=5.12%, p < 0.05). Cone/usion:These results
suggest that apoptoaia might play a role on the progression in myocerdial
damage especially in DCM, and Fas system may mediate an apoptosis in
cardiomyopathy.
1995-59] ROleofNitric@idei nAWteAdriamY~in~ o~i~itY
1.Trittol, O. D’Andrea, A. Scognamiglio, C. Battaglia, P.P.Elia, C. De
Simone, A. Violante, M. Chiariello, G. Ambrosio’. Division of Cardiology,
University of Naples, Italy, 1Division of Cardiology, University of Perugia,
Italy
Adriamycin (ADR) cardiotoxicity has been related to oxygen radical (OR)
generation. However, the exact mechanism of this phenomenon is etill un-
known. We have recently shown that exposure to ADR severely impairs both
endothelium dependent end independent vasodilation in isolated vessela,
and that this toxic effect waa prevented either by OR scavenging, or by in-
hibiting nitric oxide formation. These findings indicate that both ORsand nitric
oxide play a role in mediating ADR vascular toxicity, most likely through for-
mation of the powerful oxidant peroxynitrite. In the heart, we have previously
demonstrated that acute ADR toxicity can be prevented by OR s~venging.
To test whether nitdc oxide is also involved in acute cardiac ADR toxicity,
isolated rabbit hearta wera perfused with 300 PM ADR for 60 rein, followed
by20 min waah-out (ADR; n =6). Another group received ADR plus the nitric
oxide aynthaee inhibitor Nw-nitro-L-argininemethyl ester (L-NAME, 300 #M;
n =7). ADR infuaion markedly affected left ventricular function. In fact, at the
end of wash-out left ventricular developed pressure (DP) was 32* 15%,and
enddieetolic pressure (EDP) was 643 + 23W0 of baseline. Administration
of L-NAME largely prevented both alterations; these effects persisted after
L-NAME wash out (DP 79 + 7%, EDP 206 * 36Y0 of baseline; p s 0.05
vs ADR). In additional experiments we verified that L-NAME has no oxygen
radical scavenging prope~. These date show that the acute impairment of
contractile function induced by ADR in isolated hearts can be prevented by
inhibiting nitric oxide synthesis. Taken together with previous data showing
that cardiac ADR toxicity can also be prevanted by OR scavengers, these
reaultesuppd the hypothesis that also in the heart acute ADR toxicity could
be mediated by peroxynitrite, formed in the reaction between oxygen radicals
(generated by ADR) and nitric oxide.
D99560 Proinflammstory Cytokine mRNA and Protein
Expression in Acute Chageaic Cardiomyopathy
B. Chandrasekar, P.C,Melby, G.L, Freeman. Tha University of TexasHea/fh
Scienca Cantec San Antonio, TX, USA, Audie L. Murphy Memorial
VeteransHospita/, San Antonio, TX, USA
Acute Chageeiccerdiomyopathy follows infection bytheflagellate Tryparrosoma
cruzi, and is felt to represent an inflammatory condition disproportionate to
the cardiac burden of organisms. The degree of production of proinflamma-
tory cytokines within the infected myocerdium, and the time course of their
expression, is not known, Accordingly, we studied one month-old male Lewis
rata inoculated with cell culture-derived T cruzi trypomastigotes. Rats were
killed 36 hours (h), 5, 10 and 15 days after infection (n = 6/group). Saline
injected rats were used as control (n = 6). Hearts were collected for histology,
mRNA, and protein analyses. Histologic analysis of myocardium showed few
changes 36 h post inoculation (pi.); by day 5, dense intracellular infection
with amastigotes and a minimal inflammatory infiltrate was noted. on day
15, dense infection and diffuse inflammatory infiltrate was seen. Northern
blots of total RNA (densitometry; ratio of specific gene to 26S rRNA; mean &
SEM) showed no signal for IL-lfJ or TNF-a, and a weak signal for IL-6 (0.32
+ 0.1) in control hearts, and high levels of expression for the three genes
at 36 h pi. (IL-16, 0.47 + 0.2; IL-6, 0.69 + 0.2; TNFw, 0.67 + 0.24). By
day 5, TNF-a mRNA levels were the highest, while IL-18 and IL-6 (1.8-fold)
levels increased substantially and peaked by the IDfh day (by at least 2.6-
fold). On day 15, IL-lB and IL-6 Ievela still remained high but of TNF-u fell.
Western blota showed similar results as that of mRNA, except that TNF-a
levels remained high even at 15 day pi. We cone/ude: In addition to me-
chanical damage by T cruzi, substantial proinflammatory cytokine production
within the myocerdium participates in the pathophysiology of acute Chaga-
sic cardiomyopathy.These proteins may contribute to myocardial contractile
dysfunction in this condition.
D99561 ArginineVasopresain-VlaRecaptormRNALevels
areReducedinthe FaiiingRatMyocardium
Y.Chandraahekhar,S, Sen, S. Roy, D.S. Liu, 1.Anand. VAMedical CTR&
tJnivof Minnesota, Minneapolis, MN, USA
Arginine Vasopreasin(AVP) is increased in congestive heart failure (CHF) but
it is unknown if this causes down-regulation of the cardiac AVP-Vla receptor.
We have previously found that the functional effects (in terms of mechanical
function and intracellular calcium transient kinetics) of a specific Via agonist
were reduced in isolated cardiomyccytes from rats with CHF, suggesting
“functional down-regulation” of the Vla receptor, but the mechanisms were
unclear, We tharefore isolated and quantitated Vla receptor mRNA (using
RT-PCRwith Vla receptor spacific primers) from the myocardium of 2groups
of rats (n = 4) –CHF, 6 weeks after an anterior infarct (LVdeveloped pressure
120 + 5.0 vs 101 + 3 mmHg & LVEDP6 + 2VS 14 + 2 mmHg; Sham va CHF,
respectively)& matched sham operated rats. Vlareceptor mRNA levels were
significantly reduced in the heart failure rats compared to sham rats while
beta actin mRNA levels were no different.
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These data suggest for the first time that AVP-Vla receptor mRNA is
reduced in the failing adult rat myocardium & the “functional down-regulation”
of the AVP-Vla receptor seen in cardiomyocytes may have a pre translational
mechanism.
